← FDA DRUG APPROVALS

FDA ANDA · ANDA062477

GENTAMICIN SULFATE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA062477
TYPE
ANDA
ORIGINAL APPROVAL
1983-12-23
LATEST ACTION
1996-07-05
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

GENTAMICIN SULFATEDiscontinued
GENTAMICIN SULFATE EQ 0.1% BASE · OINTMENT · TOPICAL

Approval history

1996-07-05Manufacturing (CMC) · Supplement 23AP
1996-07-05Labeling · Supplement 24AP
1993-03-18Labeling · Supplement 22AP
1992-08-27Labeling · Supplement 21AP
1992-08-05Labeling · Supplement 20AP
1991-04-26Labeling · Supplement 19AP
1990-11-19Manufacturing (CMC) · Supplement 18AP
1989-06-30Manufacturing (CMC) · Supplement 17AP
1988-11-16Manufacturing (CMC) · Supplement 16AP
1983-12-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →